Nagendra R Hegde

Summary

Publications

  1. ncbi request reprint Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India
    Nagendra R Hegde
    Ella Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad 500078, India Electronic address
    Vaccine 32:3636-43. 2014
  2. doi request reprint Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination
    Nagendra R Hegde
    Ella Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad 500 078, India
    Drug Discov Today 16:1061-8. 2011
  3. doi request reprint Deep sequencing as a method of typing bluetongue virus isolates
    Pavuluri Panduranga Rao
    Ella Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad 500078, India
    J Virol Methods 193:314-9. 2013
  4. doi request reprint Use of PCR-based assays for the detection of the adventitious agent porcine circovirus type 1 (PCV1) in vaccines, and for confirming the identity of cell substrates and viruses used in vaccine production
    Deepak Kumar
    Ella Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad 500078, India
    J Virol Methods 179:201-11. 2012
  5. pmc Complete genome sequence of bluetongue virus serotype 9: implications for serotyping
    Pavuluri Panduranga Rao
    Ella Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad, India
    J Virol 86:8333. 2012
  6. doi request reprint Genetic characterization of bluetongue virus serotype 9 isolates from India
    Pavuluri Panduranga Rao
    Ella Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad 500078, India
    Virus Genes 44:286-94. 2012
  7. doi request reprint Immunotherapy of viral infections
    Nagendra R Hegde
    Bharat Biotech Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad 500078, India
    Immunotherapy 1:691-711. 2009

Collaborators

  • Xiang Jin Meng
  • Jagadeesh Bayry
  • Pavuluri Panduranga Rao
  • Yella Narasimha Reddy
  • Deepak Kumar
  • Vidya Niranjan
  • Shreeja G Nair
  • Kapila Ganesh
  • Nathan M Beach
  • Y Vishnuvardhan Reddy
  • P U V S Prasad
  • Keerti Meena
  • N Karunasree
  • B Susmitha
  • Y Narsimaha Reddy
  • P Chaitanya
  • Madala Uma

Detail Information

Publications7

  1. ncbi request reprint Development and preclinical testing of HNVAC, a cell culture-based H1N1 pandemic influenza vaccine from India
    Nagendra R Hegde
    Ella Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad 500078, India Electronic address
    Vaccine 32:3636-43. 2014
    ..This is the first and only cell culture-based influenza vaccine platform developed in any developing country. ..
  2. doi request reprint Recent advances in the administration of vaccines for infectious diseases: microneedles as painless delivery devices for mass vaccination
    Nagendra R Hegde
    Ella Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad 500 078, India
    Drug Discov Today 16:1061-8. 2011
    ..Transdermal delivery using microneedles could revolutionize the way prophylactic interventions for infectious diseases are carried out in the future...
  3. doi request reprint Deep sequencing as a method of typing bluetongue virus isolates
    Pavuluri Panduranga Rao
    Ella Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad 500078, India
    J Virol Methods 193:314-9. 2013
    ..The two viruses used in this study were typed as BTV-1 and BTV-9E. ..
  4. doi request reprint Use of PCR-based assays for the detection of the adventitious agent porcine circovirus type 1 (PCV1) in vaccines, and for confirming the identity of cell substrates and viruses used in vaccine production
    Deepak Kumar
    Ella Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad 500078, India
    J Virol Methods 179:201-11. 2012
    ..The methods can be applied for regular in-house quality control screening of raw materials and seeds/banks, as well as formulated vaccines...
  5. pmc Complete genome sequence of bluetongue virus serotype 9: implications for serotyping
    Pavuluri Panduranga Rao
    Ella Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad, India
    J Virol 86:8333. 2012
    ..The sequence analysis points to continued circulation in India of a mixed topotype virus apparently belonging to the BTV-9 serotype, and it raises questions about approaches for serotyping bluetongue viruses...
  6. doi request reprint Genetic characterization of bluetongue virus serotype 9 isolates from India
    Pavuluri Panduranga Rao
    Ella Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad 500078, India
    Virus Genes 44:286-94. 2012
    ..These results have implications on BTV origin and movement, genotyping, serotyping, and vaccine design...
  7. doi request reprint Immunotherapy of viral infections
    Nagendra R Hegde
    Bharat Biotech Foundation, Genome Valley, Turkapally, Shameerpet Mandal, Hyderabad 500078, India
    Immunotherapy 1:691-711. 2009
    ..We present an overview of various immunological strategies that have been applied for treating viral infections after exposure to the infectious agent...